Log In
Print this Print this

Ebola GP Vaccine, EBOV GP vaccine

  Manage Alerts
Collapse Summary General Information
Company Novavax Inc.
DescriptionRecombinant glycoprotein nanoparticle vaccine based on the cluster 3 gene sequence in the 2014 Makona Ebola strain
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationEbola
Indication DetailsPrevent Ebola virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today